Search Results - "Jegga, Anil G"

Refine Results
  1. 1

    Disease candidate gene identification and prioritization using protein interaction networks by Chen, Jing, Aronow, Bruce J, Jegga, Anil G

    Published in BMC bioinformatics (27-02-2009)
    “…Although most of the current disease candidate gene identification and prioritization methods depend on functional annotations, the coverage of the gene…”
    Get full text
    Journal Article
  2. 2

    Changing Trends in Computational Drug Repositioning by Yella, Jaswanth K, Yaddanapudi, Suryanarayana, Wang, Yunguan, Jegga, Anil G

    Published in Pharmaceuticals (Basel, Switzerland) (05-06-2018)
    “…Efforts to maximize the indications potential and revenue from drugs that are already marketed are largely motivated by what Sir James Black, a Nobel…”
    Get full text
    Journal Article
  3. 3

    A comparison of anatomic and cellular transcriptome structures across 40 human brain diseases by Zeighami, Yashar, Bakken, Trygve E, Nickl-Jockschat, Thomas, Peterson, Zeru, Jegga, Anil G, Miller, Jeremy A, Schulkin, Jay, Evans, Alan C, Lein, Ed S, Hawrylycz, Michael

    Published in PLoS biology (20-04-2023)
    “…Genes associated with risk for brain disease exhibit characteristic expression patterns that reflect both anatomical and cell type relationships. Brain-wide…”
    Get full text
    Journal Article
  4. 4

    Improved human disease candidate gene prioritization using mouse phenotype by Chen, Jing, Xu, Huan, Aronow, Bruce J, Jegga, Anil G

    Published in BMC bioinformatics (16-10-2007)
    “…The majority of common diseases are multi-factorial and modified by genetically and mechanistically complex polygenic interactions and environmental factors…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Computational drug repositioning through heterogeneous network clustering by Wu, Chao, Gudivada, Ranga C, Aronow, Bruce J, Jegga, Anil G

    Published in BMC systems biology (09-12-2013)
    “…Given the costly and time consuming process and high attrition rates in drug discovery and development, drug repositioning or drug repurposing is considered as…”
    Get full text
    Journal Article
  8. 8

    Consensus Gene Co-Expression Network Analysis Identifies Novel Genes Associated with Severity of Fibrotic Lung Disease by Ghandikota, Sudhir, Sharma, Mihika, Ediga, Harshavardhana H, Madala, Satish K, Jegga, Anil G

    “…Idiopathic pulmonary fibrosis (IPF) is a severe fibrotic lung disease characterized by irreversible scarring of the lung parenchyma leading to dyspnea,…”
    Get full text
    Journal Article
  9. 9

    Systems biology of the autophagy-lysosomal pathway by Jegga, Anil G., Schneider, Lonnie, Ouyang, Xiaosen, Zhang, Jianhua

    Published in Autophagy (01-05-2011)
    “…The mechanisms of the control and activity of the autophagy-lysosomal protein degradation machinery are emerging as an important theme for neurodevelopment and…”
    Get full text
    Journal Article
  10. 10

    Gene expression signature for biliary atresia and a role for interleukin‐8 in pathogenesis of experimental disease by Bessho, Kazuhiko, Mourya, Reena, Shivakumar, Pranavkumar, Walters, Stephanie, Magee, John C., Rao, Marepalli, Jegga, Anil G., Bezerra, Jorge A.

    Published in Hepatology (Baltimore, Md.) (01-07-2014)
    “…Biliary atresia (BA) is a progressive fibroinflammatory obstruction of extrahepatic bile ducts that presents as neonatal cholestasis. Due to the overlap in…”
    Get full text
    Journal Article
  11. 11
  12. 12

    The Protective Effects of IL-31RA Deficiency During Bleomycin-Induced Pulmonary Fibrosis by Yombo, Dan J K, Odayar, Varshini, Gupta, Nishant, Jegga, Anil G, Madala, Satish K

    Published in Frontiers in immunology (19-03-2021)
    “…Idiopathic Pulmonary Fibrosis (IPF) is a severe fibrotic lung disease characterized by excessive collagen deposition and progressive decline in lung function…”
    Get full text
    Journal Article
  13. 13

    Inhibition of Aurora Kinase B attenuates fibroblast activation and pulmonary fibrosis by Kasam, Rajesh K, Ghandikota, Sudhir, Soundararajan, Divyalakshmi, Reddy, Geereddy B, Huang, Steven K, Jegga, Anil G, Madala, Satish K

    Published in EMBO molecular medicine (07-09-2020)
    “…Fibroblast activation including proliferation, survival, and ECM production is central to initiation and maintenance of fibrotic lesions in idiopathic…”
    Get full text
    Journal Article
  14. 14

    Combination of esomeprazole and pirfenidone enhances antifibrotic efficacy in vitro and in a mouse model of TGFβ-induced lung fibrosis by Ebrahimpour, Afshin, Ahir, Manisha, Wang, Min, Jegga, Anil G., Bonnen, Mark D., Eissa, N. Tony, Montesi, Sydney B., Raghu, Ganesh, Ghebre, Yohannes T.

    Published in Scientific reports (30-11-2022)
    “…Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease of unknown etiology. Currently, pirfenidone and nintedanib are the only…”
    Get full text
    Journal Article
  15. 15

    IL-31-Driven Skin Remodeling Involves Epidermal Cell Proliferation and Thickening That Lead to Impaired Skin-Barrier Function by Singh, Brijendra, Jegga, Anil G, Shanmukhappa, Kumar S, Edukulla, Ramakrishna, Khurana Hershey, Gurjit H, Medvedovic, Mario, Dillon, Stacey R, Madala, Satish K

    Published in PloS one (24-08-2016)
    “…Interleukin-31 (IL-31) is a type 2 helper T-cell-derived cytokine that has recently been shown to cause severe inflammation and tissue remodeling in multiple…”
    Get full text
    Journal Article
  16. 16

    Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death by Zhang, Xiaowei, Wang, Xiaohong, Zhu, Hongyan, Zhu, Cheng, Wang, Yigang, Pu, William T, Jegga, Anil G, Fan, Guo-Chang

    “…Abstract Among the identified microRNAs (miRs) thus far, ~ 50% of mammalian miRs are clustered in the genome and transcribed as polycistronic primary…”
    Get full text
    Journal Article
  17. 17

    Heterogeneous Distribution of Genetic Mutations in Myosin Binding Protein-C Paralogs by Desai, Darshini A., Rao, Vinay J., Jegga, Anil G., Dhandapany, Perundurai S., Sadayappan, Sakthivel

    Published in Frontiers in genetics (27-06-2022)
    “…Myosin binding protein-C (MyBP-C) is a sarcomeric protein which regulates the force of contraction in striated muscles. Mutations in the MYBPC family of genes,…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Dysregulated overexpression of Sox9 induces fibroblast activation in pulmonary fibrosis by Gajjala, Prathibha R, Kasam, Rajesh K, Soundararajan, Divyalakshmi, Sinner, Debora, Huang, Steven K, Jegga, Anil G, Madala, Satish K

    Published in JCI insight (22-10-2021)
    “…Idiopathic pulmonary fibrosis (IPF) is a fatal fibrotic lung disease associated with unremitting fibroblast activation including fibroblast-to-myofibroblast…”
    Get full text
    Journal Article
  20. 20

    Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case study by Yang, Lun, Wang, Kejian, Chen, Jian, Jegga, Anil G, Luo, Heng, Shi, Leming, Wan, Chunling, Guo, Xizhi, Qin, Shengying, He, Guang, Feng, Guoyin, He, Lin

    Published in PLoS computational biology (01-03-2011)
    “…In the era of personalized medical practice, understanding the genetic basis of patient-specific adverse drug reaction (ADR) is a major challenge. Clozapine…”
    Get full text
    Journal Article